Published On: May 12th, 2010
Merck today highlighted cardiovascular pipeline with six molecules in late-stage development. Among them: anacetrapib — a molecular cousin to a drug Pfizer once had in development.

Here is the original post:
Merck To Move Ahead on a Heart Drug Where Pfizer Failed
Loading...
Leave a comment



Did you know:






